Pennant Group, Inc. (The) (PNTG)
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-09-09
$39.60+0.74%
Close 2026-09-09 · 1-day change
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-09-09
Intact: The reason to own it still holds.
Pennant Group grows revenue steadily, aiming for $1.133B-$1.172B in 2026. Profit per share targets $1.26-$1.36, showing solid earnings. Recent acquisitions and software upgrades boost growth. The company has a strong footprint in healthcare facilities across multiple states.
Profit growth is uncertain with EPS at $0.24 in Q1, below target pace. The company’s valuation is high with a PE of 33.6, risking a correction. Soft guidance signals possible margin or execution challenges.
The market prices in about 15% revenue growth and values the stock roughly 18% above our fair value near $33.5. We agree growth is strong but see risk in meeting EPS and EBITDA targets given soft guidance.
Breaks if: EPS falls below $1.26 in FY26
Breaks if: EBITDA falls below $94.2 million in FY26
Breaks if: annual revenue falls below $1.133 billion in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This is a stable growth investment with a focus on achieving specific financial targets. The current thesis state is intact, supported by strong recent financial performance, but it remains sensitive to external economic factors.
The market currently prices PNTG at a premium compared to peers, reflecting expectations of continued strong performance. However, there is a slight expectations gap, indicating that some fragility in execution is already accounted for.
Management is on track to meet its revenue and earnings targets for 2026, with strong growth reported in recent quarters. However, there is a moderate risk of missing these targets, especially given the company's smaller size and recent history of volatility.
The thesis hinges on maintaining guidance and performance in the face of potential economic downturns and sector performance. Key factors include the performance of sector bellwethers and any changes in guidance during upcoming earnings calls.
Over the next 1 to 3 years, PNTG's performance will depend on management's execution and external market conditions. Not investment advice.
The most important moves since the prior daily snapshot.
Signal changed from 'mild_favorable' to 'mixed'.
Valuation fell by 10.6 points (from 44.3 to 33.7).
Yes, our read has strengthened. The latest earnings beat supports the positive outlook. Securing a second US defense contract via Siemens enhances operational excellence and growth.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.